⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL37779 | 0.67 | — | — | |
| SCHEMBL367039 | 0.66 | — | — | |
| SCHEMBL3389306 | 0.62 | — | — | |
| SCHEMBL21221329 | 0.62 | — | — | |
| SCHEMBL11127981 | 0.62 | — | — | |
| SCHEMBL22188744 | 0.62 | — | — | |
| SCHEMBL1577820 | 0.59 | — | — | |
| SCHEMBL21075879 | 0.59 | PDK1 (0.34) | — | |
| SCHEMBL23346573 | 0.57 | — | — | |
| Ethylenediamine SCHEMBL11157028 | 0.57 | KEAP1 (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117279926-A | Method for producing oligonucleotide compound | 日本新药株式会社 | 2023-12-22 | — | — | CN | claimed |
| CN-117897484-A | Antisense oligonucleotides and their use for treating neurodegenerative disorders | 卫材R&D管理有限公司 | 2024-04-16 | — | — | CN | disclosed |